Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Early trials for immune checkpoint inhibitors in sarcomas have delivered mixed results, and efforts to improve outcomes now look to combinatorial strategies with novel immunotherapeutics, including some that target macrophages. To enhance our understanding of the sarcoma immune landscape, we quantif...

Descripción completa

Detalles Bibliográficos
Autores principales: Dancsok, Amanda R., Gao, Dongxia, Lee, Anna F., Steigen, Sonja Eriksson, Blay, Jean-Yves, Thomas, David M., Maki, Robert G., Nielsen, Torsten O., Demicco, Elizabeth G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153829/
https://www.ncbi.nlm.nih.gov/pubmed/32313727
http://dx.doi.org/10.1080/2162402X.2020.1747340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153829/
https://www.ncbi.nlm.nih.gov/pubmed/32313727
http://dx.doi.org/10.1080/2162402X.2020.1747340

Ejemplares similares